These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15363178)

  • 1. Novel pulse duplicating bioreactor system for tissue-engineered vascular construct.
    Narita Y; Hata K; Kagami H; Usui A; Ueda M; Ueda Y
    Tissue Eng; 2004; 10(7-8):1224-33. PubMed ID: 15363178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion bioreactor for small diameter tissue-engineered arteries.
    Williams C; Wick TM
    Tissue Eng; 2004; 10(5-6):930-41. PubMed ID: 15265311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic pulsatile flow bioreactor conditioning of poly(ethylene glycol)-based tissue engineered vascular grafts.
    Hahn MS; McHale MK; Wang E; Schmedlen RH; West JL
    Ann Biomed Eng; 2007 Feb; 35(2):190-200. PubMed ID: 17180465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered constructs.
    Shaikh FM; O'Brien TP; Callanan A; Kavanagh EG; Burke PE; Grace PA; McGloughlin TM
    Artif Organs; 2010 Feb; 34(2):153-8. PubMed ID: 19995361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves.
    Hildebrand DK; Wu ZJ; Mayer JE; Sacks MS
    Ann Biomed Eng; 2004 Aug; 32(8):1039-49. PubMed ID: 15446500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bioreactors in tissue engineering.
    Martin I; Wendt D; Heberer M
    Trends Biotechnol; 2004 Feb; 22(2):80-6. PubMed ID: 14757042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
    Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
    Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pulsatile bioreactor culture on vascular smooth muscle cells seeded on electrospun poly (lactide-co-ε-caprolactone) scaffold.
    Mun CH; Jung Y; Kim SH; Kim HC; Kim SH
    Artif Organs; 2013 Dec; 37(12):E168-78. PubMed ID: 23834728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioreactor for application of subatmospheric pressure to three-dimensional cell culture.
    Wilkes RP; McNulty AK; Feeley TD; Schmidt MA; Kieswetter K
    Tissue Eng; 2007 Dec; 13(12):3003-10. PubMed ID: 17988192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile perfusion bioreactor system for durability testing and compliance estimation of tissue engineered vascular grafts.
    Diamantouros SE; Hurtado-Aguilar LG; Schmitz-Rode T; Mela P; Jockenhoevel S
    Ann Biomed Eng; 2013 Sep; 41(9):1979-89. PubMed ID: 23681651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro culture of large bone substitutes in a new bioreactor: importance of the flow direction.
    Olivier V; Hivart P; Descamps M; Hardouin P
    Biomed Mater; 2007 Sep; 2(3):174-80. PubMed ID: 18458469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes.
    Baguneid M; Murray D; Salacinski HJ; Fuller B; Hamilton G; Walker M; Seifalian AM
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):151-7. PubMed ID: 15032735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds.
    Jeong SI; Kwon JH; Lim JI; Cho SW; Jung Y; Sung WJ; Kim SH; Kim YH; Lee YM; Kim BS; Choi CY; Kim SJ
    Biomaterials; 2005 Apr; 26(12):1405-11. PubMed ID: 15482828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioreactor technology in cardiovascular tissue engineering.
    Mertsching H; Hansmann J
    Adv Biochem Eng Biotechnol; 2009; 112():29-37. PubMed ID: 19290496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotating versus perfusion bioreactor for the culture of engineered vascular constructs based on hyaluronic acid.
    Arrigoni C; Chittò A; Mantero S; Remuzzi A
    Biotechnol Bioeng; 2008 Aug; 100(5):988-97. PubMed ID: 18383121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a modular bioreactor to incorporate both perfusion flow and hydrostatic compression for tissue engineering applications.
    Orr DE; Burg KJ
    Ann Biomed Eng; 2008 Jul; 36(7):1228-41. PubMed ID: 18438713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deformation simulation of cells seeded on a collagen-GAG scaffold in a flow perfusion bioreactor using a sequential 3D CFD-elastostatics model.
    Jungreuthmayer C; Jaasma MJ; Al-Munajjed AA; Zanghellini J; Kelly DJ; O'Brien FJ
    Med Eng Phys; 2009 May; 31(4):420-7. PubMed ID: 19109048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical monitoring during bioreactor conditioning of tissue-engineered heart valves.
    Ziegelmueller JA; Zaenkert EK; Schams R; Lackermair S; Schmitz C; Reichart B; Sodian R
    ASAIO J; 2010; 56(3):228-31. PubMed ID: 20335802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new bioreactor for the development of tissue-engineered heart valves.
    Ruel J; Lachance G
    Ann Biomed Eng; 2009 Apr; 37(4):674-81. PubMed ID: 19165600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.